Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Evaluation of body fat composition after linagliptin treatment in a rat model of diet-induced obesity: a magnetic resonance spectroscopy study in comparison with sibutramine.

Klein T, Niessen HG, Ittrich C, Mayoux E, Mueller HP, Cheetham S, Stiller D, Kassubek J, Mark M.

Diabetes Obes Metab. 2012 Nov;14(11):1050-3. doi: 10.1111/j.1463-1326.2012.01629.x.

PMID:
22651241
2.
3.

Regulation of body weight and carcass composition by sibutramine in rats.

Strack AM, Shu J, Camacho R, Gorski JN, Murphy B, MacIntyre DE, Hickey GJ.

Obes Res. 2002 Mar;10(3):173-81.

4.

Effects of the DPP-4 inhibitor, linagliptin, in diet-induced obese rats: a comparison in naive and exenatide-treated animals.

Vickers SP, Cheetham SC, Birmingham GD, Rowley HL, Headland KR, Dickinson K, Grempler R, Hocher B, Mark M, Klein T.

Clin Lab. 2012;58(7-8):787-99.

PMID:
22997980
5.

Effect of sibutramine on regional fat pads and leptin levels in rats fed with three isocaloric diets.

Stroubini T, Perrea D, Perelas A, Liapi C, Dontas I, Trapali M, Katsilambros N, Galanopoulou P.

Eur Cytokine Netw. 2008 Sep;19(3):149-55. doi: 10.1684/ecn.2008.0130.

6.

Effect of isocaloric diets and sibutramine on food intake, body mass variation and serum TNF-alpha levels in rats.

Trapali M, Liapi C, Perelas A, Perrea D, Stroubini T, Dontas I, Couvari E, Mavri M, Galanopoulou P.

Pharmacology. 2008;82(1):15-21. doi: 10.1159/000127363.

PMID:
18434760
7.

Sibutramine alters the central mechanisms regulating the defended body weight in diet-induced obese rats.

Levin BE, Dunn-Meynell AA.

Am J Physiol Regul Integr Comp Physiol. 2000 Dec;279(6):R2222-8.

8.

Effects of a novel Y5 antagonist in obese mice: combination with food restriction or sibutramine.

Mashiko S, Ishihara A, Iwaasa H, Moriya R, Kitazawa H, Mitobe Y, Ito J, Gomori A, Matsushita H, Takahashi T, MacNeil DJ, Van der Ploeg LH, Fukami T, Kanatani A.

Obesity (Silver Spring). 2008 Jul;16(7):1510-5. doi: 10.1038/oby.2008.223.

9.

Serum adiponectin and resistin in rats under three isocaloric diets: The effect of sibutramine.

Stroubini T, Perelas A, Liapi C, Perrea D, Dontas I, Tzavara Ch, Galanopoulou P.

Cytokine. 2009 May;46(2):171-5. doi: 10.1016/j.cyto.2009.01.003.

PMID:
19251435
10.
11.

Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats.

Roth JD, Trevaskis JL, Wilson J, Lei C, Athanacio J, Mack C, Kesty NC, Coffey T, Weyer C, Parkes DG.

Int J Obes (Lond). 2008 Aug;32(8):1201-10. doi: 10.1038/ijo.2008.91.

PMID:
18560368
12.
13.

Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia.

Dujovne CA, Zavoral JH, Rowe E, Mendel CM; Silbutramine Study Group..

Am Heart J. 2001 Sep;142(3):489-97.

PMID:
11526363
14.

The DPP-IV inhibitor linagliptin and GLP-1 induce synergistic effects on body weight loss and appetite suppression in the diet-induced obese rat.

Hansen HH, Hansen G, Paulsen S, Vrang N, Mark M, Jelsing J, Klein T.

Eur J Pharmacol. 2014 Oct 15;741:254-63. doi: 10.1016/j.ejphar.2014.08.010.

PMID:
25160746
15.

Synergy of sibutramine and low-dose leptin in treatment of diet-induced obesity in rats.

Boozer CN, Leibel RL, Love RJ, Cha MC, Aronne LJ.

Metabolism. 2001 Aug;50(8):889-93.

PMID:
11474475
16.

MRI allows for longitudinal quantitative analysis of body fat composition in rats: an analysis of sibutramine-associated changes at the group level.

Müller HP, Niessen HG, Kaulisch T, Ludolph AC, Kassubek J, Stiller D.

Magn Reson Imaging. 2013 Sep;31(7):1150-5. doi: 10.1016/j.mri.2013.02.011.

PMID:
23664824
17.

Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome.

Madsen AN, Hansen G, Paulsen SJ, Lykkegaard K, Tang-Christensen M, Hansen HS, Levin BE, Larsen PJ, Knudsen LB, Fosgerau K, Vrang N.

J Endocrinol. 2010 Sep;206(3):287-96. doi: 10.1677/JOE-10-0004.

18.

Randomized placebo-controlled trial of long-term treatment with sibutramine in mild to moderate obesity.

Smith IG, Goulder MA; Sibutramine Clinical Study 1047 Team..

J Fam Pract. 2001 Jun;50(6):505-12.

PMID:
11407998
19.

Sibutramine. A review of its contribution to the management of obesity.

McNeely W, Goa KL.

Drugs. 1998 Dec;56(6):1093-124. Review.

PMID:
9878996
20.

Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.

Florakis D, Diamanti-Kandarakis E, Katsikis I, Nassis GP, Karkanaki A, Georgopoulos N, Panidis D.

Int J Obes (Lond). 2008 Apr;32(4):692-9.

PMID:
18071341
Items per page

Supplemental Content

Support Center